Press releases
- Roche receives FDA clearance on its digital pathology solution for diagnostic use
- Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing
- Roche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for ENHERTU
Key statistics
As of last trade Chugai Pharmaceutical Co Ltd (CUP:DUS) traded at 33.42, -16.45% below its 52-week high of 40.00, set on Mar 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 33.96 |
---|---|
High | 33.96 |
Low | 33.42 |
Bid | 33.38 |
Offer | 34.31 |
Previous close | 33.23 |
Average volume | 66.67 |
---|---|
Shares outstanding | 1.68bn |
Free float | 673.12m |
P/E (TTM) | 29.17 |
Market cap | 9.72tn JPY |
EPS (TTM) | 198.34 JPY |
Annual div (ADY) | 0.5112 EUR |
---|---|
Annual div yield (ADY) | 1.58% |
Div ex-date | Dec 28 2023 |
Div pay-date | Mar 29 2024 |
Data delayed at least 15 minutes, as of Jul 03 2024 08:30 BST.
More ▼